Stones: Diet and Pharmacologic Management: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
Line 100: | Line 100: | ||
**'''Patients placed on thiazide diuretics for management of hypercalciuria should also be placed on dietary sodium restriction''' | **'''Patients placed on thiazide diuretics for management of hypercalciuria should also be placed on dietary sodium restriction''' | ||
***'''An excess sodium load will inhibit reabsorption of calcium in the proximal tubule, thereby causing hypercalciuria.''' | ***'''An excess sodium load will inhibit reabsorption of calcium in the proximal tubule, thereby causing hypercalciuria.''' | ||
*'''Adverse events''' | *'''<span style="color:#ff0000">Adverse events''' | ||
**'''Lassitude and sleepiness''' | **'''<span style="color:#ff0000">Lassitude and sleepiness''' | ||
***'''Most common side effects of thiazides''' | ***'''Most common side effects of thiazides''' | ||
***Can occur in the absence of hypokalemia | ***Can occur in the absence of hypokalemia | ||
***Usually seen on initiation of treatment but resolves with continued therapy. | ***Usually seen on initiation of treatment but resolves with continued therapy. | ||
**'''Metabolic/electrolyte abnormalities''' ('''3 hypers, 3 hypos + metabolic alkalosis''') | **'''<span style="color:#ff0000">Metabolic/electrolyte abnormalities''' ('''3 hypers, 3 hypos + metabolic alkalosis''') | ||
**#'''Hyperglycemia''' | **#'''<span style="color:#ff0000">Hyperglycemia''' | ||
**#'''Hyperlipidemia''' | **#'''<span style="color:#ff0000">Hyperlipidemia''' | ||
**#'''Hyperuricemia''' | **#'''<span style="color:#ff0000">Hyperuricemia''' | ||
**#'''Hypokalemia''' | **#'''<span style="color:#ff0000">Hypokalemia''' | ||
**#'''Hypomagnesemia''' | **#'''<span style="color:#ff0000">Hypomagnesemia''' | ||
**#'''Hypocitraturia''' | **#'''<span style="color:#ff0000">Hypocitraturia''' | ||
**#'''Metabolic alkalosis''' | **#'''<span style="color:#ff0000">Metabolic alkalosis''' | ||
**'''Hypocitraturia''' | **'''Hypocitraturia''' | ||
***'''Result of hypokalemia with intracellular acidosis''' | ***'''Result of hypokalemia with intracellular acidosis''' | ||
Line 147: | Line 147: | ||
**'''Patient's treated with sodium alkali will occasionally begin forming calcium oxalate stones due to an excess sodium load that will inhibit reabsorption of calcium in the proximal tubule, thereby causing hypercalciuria''' | **'''Patient's treated with sodium alkali will occasionally begin forming calcium oxalate stones due to an excess sodium load that will inhibit reabsorption of calcium in the proximal tubule, thereby causing hypercalciuria''' | ||
**'''If the patient is at risk for hyperkalemia, other agents such as sodium bicarbonate or sodium citrate should be considered.''' | **'''If the patient is at risk for hyperkalemia, other agents such as sodium bicarbonate or sodium citrate should be considered.''' | ||
===Recurrent calcium stones=== | ===Recurrent calcium stones=== | ||
*'''<span style="color:#ff0000">Allopurinol should be offered to patients with recurrent calcium oxalate stones who have hyperuricosuria and normal urinary calcium</span>''' | *'''<span style="color:#ff0000">Allopurinol should be offered to patients with recurrent calcium oxalate stones who have hyperuricosuria and normal urinary calcium</span>''' |